Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Advances in Cancer Research
|
October 2, 2012
Chapter two--Adenovirus strategies for tissue-specific targeting
Matthew S Beatty, David T Curiel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2009
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis
Diptiman Chanda, Tatyana Isayeva, Sanjay Kumar, et al.
Journal of Molecular Biology
|
September 13, 2008
Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid
Carmen San Martín, Joel N Glasgow, Anton Borovjagin, et al.
Frontiers in Immunology
|
October 30, 2023
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer
Sarah Bazargan, Brittany Bunch, Awino Maureiq E Ojwang', et al.
Journal for Immunotherapy of Cancer
|
April 8, 2025
CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion
Renata Ariza Marques Rossetti, Leticia Tordesillas, Matthew S Beatty, et al.
The Journal of Biological Chemistry
|
February 17, 2018
Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon
Afua A Akuffo, Aileen Y Alontaga, Rainer Metcalf, et al.
Biomedicines
|
February 24, 2024
L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Oluwaseyi E Oluwatola, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
L-DOS47 enhances response to immunotherapy in pancreatic cancer tumor
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Dominique Abrahams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Advances in Cancer Research
|
October 2, 2012
Chapter two--Adenovirus strategies for tissue-specific targeting
Matthew S Beatty, David T Curiel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2009
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis
Diptiman Chanda, Tatyana Isayeva, Sanjay Kumar, et al.
Journal of Molecular Biology
|
September 13, 2008
Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid
Carmen San Martín, Joel N Glasgow, Anton Borovjagin, et al.
Frontiers in Immunology
|
October 30, 2023
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer
Sarah Bazargan, Brittany Bunch, Awino Maureiq E Ojwang', et al.
Journal for Immunotherapy of Cancer
|
April 8, 2025
CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion
Renata Ariza Marques Rossetti, Leticia Tordesillas, Matthew S Beatty, et al.
The Journal of Biological Chemistry
|
February 17, 2018
Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon
Afua A Akuffo, Aileen Y Alontaga, Rainer Metcalf, et al.
Biomedicines
|
February 24, 2024
L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Oluwaseyi E Oluwatola, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
L-DOS47 enhances response to immunotherapy in pancreatic cancer tumor
Bruna Victorasso Jardim-Perassi, Pietro Irrera, Dominique Abrahams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Page
of 2